PaxMedica Net Income

The latest net income for PXMD is $-18M as of June 2024. That compares with $-33M in the prior-year period — up 46.2% year over year. That is below the sector sector average of $87M. Investors often review this figure alongside PaxMedica's historical trend and sector peers before judging valuation or financial health.

Over the past year, PXMD's net income moved from $-33M to $-18M — a 46.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PaxMedica's operating scale or balance-sheet position.

Against its sector companies, PXMD currently prints $-18M for net income, while the sector average sits near $87M. That is roughly 120.4% below the sector mean. Large gaps often invite a closer look at PaxMedica's growth, margins, and balance sheet.

A net income figure of $-18M for PXMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $87M. Explore the charts below for those layers of context.

After noting PXMD's net income ($-18M), review year-over-year change from $-33M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.